Control of pain - the most important component of the dentist and is the main indicator of the quality of his work in the eyes of the patient. Sanofi-aventis Group is a recognized expert in the field of anesthesiology: it is in the laboratories of the company Hoechst AG (a division of Sanofi-Aventis Group) in 1905 was synthesized Novocain in 1955 - baralgin, and in 1969 - the first local anesthetic artikainovogo series - Ultrakain ®. Ultrakain ® in comparison with other local anesthetics has several unique characteristics: for toxicity, slightly exceeding novocaine, it exceeds the strength of novocaine in 5 times. Since 1978, when Ultrakain ® entered the dental practice, until 2000 the world was made 86 billion injection Ultrakaina (Grigoleit N., 1996), and during that time found only 10 cases of allergic reaction to this original drug. Largely due Ultrakainu dental treatment from the sophisticated torture in the past has become in our days in a painless procedure. Working with a unique drug Ultrakain gives doctors another distinct advantage: the possibility of more frequent use of the latest sound methods of anesthesia, such as infiltration method return conductor. Choosing modern anesthetic Ultrakain, a practicing dentist gets a guaranteed quality of analgesia with rapid onset of effect, proven hypoallergenic product, the low occurrence of side effects. The unique structure karpuly Ultrakaina, namely: high quality glass and rubber parts karpuly, the 4 o-rings, graduation, special openings for aspiration, a color display, contributes to high quality and comfortable dental work - a professional. Ultrakain produced in Germany at the factories of the company Sanofi-Aventis, which is a pharmaceutical company, which is subject to increased demands in matters of safety and quality produced by anesthetics. Pleasing to note that in 2007 Russia's sale of dentists there is a new form of drug - Ultrakain D (artikain without epinephrine). Ultrakain D has a 4-year successful experience of Germany. The duration of anesthesia when using Ultrakainom D is approximately 20 minutes. The drug is optimal when working with patients with a history of allergological (vasoconstrictor no preservative - sodium metabisulfit) for patients with severe cardiovascular diseases, gerontology and child dentistry, to work with somatically healthy patients who require a short intervention, as well as the use of small volume of anesthetic (for example, in the incisors and canines). The drug is safe for pregnant and lactating women. Ultrakain D has a higher efficiency in comparison with the preparations on the basis of mepivacaine, as the active ingredient Ultrakaina - artikain, and toxicity - lower. (R. Rahn, 1996) Ultrakain available in forms with different concentrations of adrenaline in karpulah, the inscriptions on which are shown in a different color depending on the concentration of vasoconstrictor. Thus, the presence of Russia's market of the product line Ultrakain doctor gives confidence in the result, the freedom to use the latest sound methods of anesthesia, as well as the possibility of developing an individual approach in treating patients of all ages, physical health and concomitant pathology. With this instrument anesthesia is effective and safe for the dentist and patient - a painless and comfortable.